acid (LTA; one unit of LTA polymer) [9] , peptidoglycan (PGN; acetylmuramyl-alanylisoglutamine) [10] have shown that all these ligands bind at one of these two repeating contact sites. Unlike other PGRPs which tend to differentiate between Gram-negative and Grampositive bacteria and bind selectively to one of them [11] , CPGRP-S binds to both types of bacterial surfaces with nearly similar affinities [9, 10] . In view of this, it is pertinent to examine the full range of versatility of the binding by CPGRP-S to a variety of bacterial cell surface molecules so that the potential of its clinical applications could be realized. Therefore, we have carried out binding studies of CPGRP-S with heparin disaccharide and determined the crystal structure of CPGRP-S complexed with heparin disaccharide. The structure determination showed that heparin disaccharide binds to CPGRP-S tightly and forms a number of contacts with protein atoms including ionic, hydrogen bonded and van der Waals interactions. It was noteworthy that the binding region occupied by heparin in CPGRP-S is the same as reported for the glycan moieties of LPS [9] , LTA [9] and PGN [10] . However, it may be mentioned here that the structures of the complexes of human Cterminal domain of PGRP-Iα with muramyl tripeptide (MTP) [12] and human C-terminal domain of PGRP-Iβ with muramyl pentapeptide (MPP) [13] have been reported.
Materials and methods

Purification of protein
Fresh mammary gland secretions of camel were obtained from the National Research Center on Camels (NRCC), Bikaner, India. The protein was purified to homogeneity from fresh camel milk samples using a two step column chromatography as described earlier [6] . The purity of protein was checked on sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) and matrix assisted laser desorption /ionizationtime of flight (MALDI-TOF) that showed a single band on SDS-PAGE and one peak in MALDI-TOF. The amino acid sequence [5] of CPGRP-S showed that it lacks potential glycosylation sites with Asn-X-Ser/Thr sequence motifs.
Surface plasmon resonance spectroscopy
The direct binding experiments were carried out using a BIAcore 2000 instrument (BIAcore, Uppsala, Sweden) as described previously [6] . The methodology used is based on surface plasmon resonance (SPR). CPGRP-S was covalently coupled to a CM5 Sensor Chip (BIAcore) following the manufacturer's instructions. The control flow-cells consisted of immobilized bovine serum albumin (BSA). Heparin disaccharide obtained from Sigma-Aldrich (St Louis, MO, USA) was dissolved in PBS and injected at a flow rate of 10 µl/min at 25°C using the multichannel mode. The regeneration of the sensor surface was achieved by short pulses of 0.1 M NaOH or/and repeated washes with buffer. The data analysis was carried out with BIAcore 3.0 evaluation software provided by the manufacturer.
Crystallization
The purified samples of protein were dissolved in the buffer containing 50mM Tris-HCl, pH 8.0 to a final concentration of 15 mg/ml. 10 µl of protein solution was mixed with equal volume of the reservoir solution containing 10% Polyethylene glycol-3350 (PEG-3350) and 0.2 M Sodium potassium tartrate. The 10 µl drops of protein solution were set up in the hanging drop vapor diffusion setup against the above reservoir solution. Crystals appeared after about a week. The freshly grown crystals of CPGRP-S were soaked in the reservoir solution containing heparin disaccharide at a concentration of 30 mg/ml.
X-ray intensity data collection and processing
The soaked crystals of CPGRP-S were stabilized in the reservoir solution to which 30% glycerol was added for the data collection at low temperature. A single crystal was mounted in a nylon loop and flash -frozen in a stream of nitrogen gas at 100 K. The data were collected using the DBT-sponsored beamline BM-14 at ESRF, Grenoble, France with a wavelength, λ = 0.98 Å using a 165 mm MAR CCD detector (MAResearch, Norderstedt, Germany). The data were processed with DENZO and SCALEPACK from HKL package [14] . The final data set was complete to 96.2% to 2.8 Å resolution. The crystals belong to orthorhombic space group I222 with unit cell dimensions of a = 88.4 Å, b = 101.7 Å, c = 162.8 Å. The presence of four molecules per asymmetric unit gave a crystal volume (Vm) of 2.41 Å 3 Da -1 per protein mass corresponding to a solvent content of 48.8% by volume. The results of data collection and proc-essing are given in Table 1 .
Structure determination and refinement
Crystal structure of the complex was determined using molecular replacement method with program MOLREP [15] . The coordinates of a monomer from the structure of native CPGRP-S (PDB ID: 3C2X) were used as a model for the structure determination. It yielded a clear solution. The refinement was carried out with program CNS [16] . At each refinement step |2Fo -Fc| and |Fo -Fc| maps were calculated for manual model building using the program O [17] on Silicon Graphics O2 workstation. A subset comprising 2% of the reflections was not used in the refinement to allow for calculations of free Rfactor. Further cycles of refinement reduced the crystallographic R-factor to 0.281 (free R-factor to 0.311). At this stage a non-protein electron density at 2.0σ cut off in the |Fo -Fc| map was observed into which heparin disaccharide was modelled ( Figure 1A ). At the same time (2Fo-Fc) map was also calculated for the region where heparin disaccharide binding occurred to show relative density at 1.2σ cut off (blue) for heparin disaccharide and surrounding residues. A density map (2Fo-Fc) at high cut off at 2.5σ (red) was also drawn. It showed comparable electron densities for both protein residues and heparin disaccharide ( Figure 1B ). At this stage, the positions of water oxygen atoms were also determined when observed as spherical peaks at a level of at least 3.0σ in |Fo -Fc| maps, provided they formed suitable hydrogen bonds with protein partners in the model. The water molecules that failed to appear at 2.0σ in the subsequent |2Fo -Fc| maps following further rounds of re- finement were removed from the model. Towards the end of refinement, additional sites with non-protein electron densities at 2.5σ cutoff in the |Fo -Fc| map were also observed into which one tartrate molecule and one glycerol molecule were fitted and added into the model and refined. The refinement using a bulk solvent model was included in the final stages that resulted in considerable improvement in the Rfactor for data in the low-resolution shell. The final values of Rcryst and Rfree factors were 20.5% and 23.4% respectively. The quality of the model was assessed using PROCHECK [18] . The coordinates for the final model have been deposited at Rutgers University Protein Data Bank with accession code 3OGX.
Results
Surface plasmon resonance spectroscopic analysis
The evaluation of binding affinity of heparin disaccharide towards CPGRP-S was carried out using the real time surface plasmon resonance (SPR) spectroscopy. The SPR sensograms illustrating the nature of association and dissociation for heparin disaccharide are given in Figure  2A . The curve-fitting process was also carried out which showed a good agreement on fitting the data ( Figure 2B ). The overall fitting of the observed data to the 1:1 association model obtained with BIA-evaluation 3.0 software package gave the value of 3.3×10 -7 M for the dissociation constant (Kd) for the complex of CPGRP-S with heparin disaccharide.
Quality of model
The final model consists of 5348 protein atoms from four crystallographically independent protein molecules in the asymmetric unit, a tightly bound heparin disaccharide, a tartrate molecule bound at the C-D interface and one glycerol molecule located at the surface ( Figure 3 ). The positions of 303 water oxygen atoms were also determined using difference Fourier maps (FoFc). The final crystallographic R-factor is 20.5% (Rfree = 23.4%). A Ramachandran plot [19] for the whole protein molecule shows 90.8% of residues in the most favoured regions as calculated using PROCHECK [18] . The summary of refinement statistics is given in Table 1 .
Overall structure
The structure determination of CPGRP-S re- 
Interactions between CPGRP-S and heparin disaccharide
Heparin disaccharide is a negatively charged molecule with two glycan residues. The position of heparin disaccharide coincides with the positions of glycan moieties of other PAMPs as observed in the structures of the complexes of CPGRP-S with LPS [9] , LTA [9] and PGN [10] . Heparin disaccharide interacts extensively with protein atoms (Table 2 ). There are atleast 19 ionic or hydrogen bonded interactions and approximately 100 van der Waals contacts between CPGRP-S and heparin disaccharide. 
Discussion
The crystal structure determination of CPGRP-S had revealed the presence of four crystallographically independent molecules A, B, C and D in the asymmetric unit [6] . The visual inspection of these four subunits indicated that they formed two dimers, A-B and C-D. However, a further analysis of the model using PISA [20] suggested that it formed linear polymers with C- D and A-B contacts repeating alternatively (Figure 4) as the buried interface areas at two interfaces were comparable. As shown by Figure  3 , heparin disaccharide bound these columns at the sites of C-D contacts. An examination of intermolecular interactions between protein and heparin disaccharide showed that heparin disaccharide formed atleast 19 hydrogen bonds and nearly 100 van der Waals contacts indicating the formation of a very stable complex of CPGRP-S with heparin disaccharide. In the scheme as shown in Figure 3 , heparin disaccharide binds primarily to molecule C. In the crystals, it was observed that it also formed a few additional interactions with molecules A and D. As seen from Figure 5 , the sulphate groups are anchored in the pockets containing residues, Lys-90, Asn-99, Gln-150 and Arg-170. An examination of the ligand binding surface shows two cavity-like subsites separated by a loop His93 -Pro100 in the protein molecule which are indicated as subsites, S-I and S-II ( Figure 6 ). Heparin occupies subsite S-I and fills it completely. Subsite S-II in the structure is slightly hindered by a loop from molecule D at the C-D interface of the protein polymer ( Figure 4) . As reported earlier the glycan moieties of other PAMPs, LPS Figure 5 . The interactions involving protein atoms (CPGRP-S) with sulphate moieties of heparin disaccharide and protein residues. The sulphate moieties S1 (PDB name: S26) forms an ionic interaction with Arg-A170, S2 (PDB name: S16) forms a salt bridge with Lys-C90 while S3 (PDB name: S20) forms three hydrogen bonds with Ala-C94, Asn-C99 and Glu-D150. [8], LTA [8] and PGN [9] were also held at the same subsite S-I. As the glycan moieties get fixed in the glycan binding pocket S-I, the hydrocarbon attachments such as those in LPS and LTA ( Figure 7A ) and peptide chain such as in PGN ( Figure 7B ) are appropriately adjusted on the protein surface. In a contrast, in the complexes of HPGRP-IαC [12] and HPGRP-IβC [13] with MTP and MPP, the glycan moieties were observed at a relatively less specific subsite, S-II due to constraints at subsite, S-I ( Figure 8A ) while peptide moieties were held at subsite, S-I indicating that the peptide moieties formed a more specific component of PGN for the recognition by HPGRP ( Figure 8B ). Since the cross-linking peptides of PGN in Gram-negative bacteria and Gram-positive bacteria contained meso -diaminopimelic acid type (Dap-type) and Llysine type (Lys-type) respectively, the peptide based recognition of such ligands would require different specificities in PGRPs. In this regard CPGRP-S is different because the initial element of recognition is the glycan moiety of PAMPs. The preference for glycan moiety may partly be due to a unique state of quaternary structure of CPGRP-S where protein molecules form A-B and C-D contacts. As the binding of heparin and other glycan moiety containing ligands occur at the C-D contacts, the ligand binding site in molecule C is further supported by its association with molecule D. 
